Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThe Mission Group Regulatory News (TMG)

Share Price Information for The Mission Group (TMG)

Share Price is delayed by 15 minutes
Get Live Data
18.50    0.00 (0.00%)
Bid:
18.00
Ask:
19.00
Spread: 1.00 (5.556%)
Market Cap: £16.76m
TMG Live PriceLast checked at - London Stock Exchange

Intraday The Mission Group Share Chart

2024 Full Year Trading Update

21 Jan 2025 07:00

RNS Number : 0261U
Mission Group PLC (The)
21 January 2025
 

21st January 2025

THE MISSION GROUP plc

("MISSION", the "Group")

2024 Full Year Trading Update

Strong, profitable growth in 2024 underpins confidence for 2025 

The MISSION Group plc (AIM:TMG), the Brand Performance Group, comprising of digital marketing and specialist communications Agencies, provides a trading update for the financial year ended 31 December 2024 ("FY2024").

 

The Group continued to see a resilient trading performance in the second half of the financial year across all segments. The Board therefore expects to report FY2024 revenue (operating income) of £88m (FY2023 +2%). The Group's diligent cost control over the course of the year underpinned profitable growth with headline operating profit expected to be between £9.0m - £9.2m; up approximately 38% on the prior year and in line with market expectations*. Headline operating margins are expected to be 10.5% for FY2024, an improvement of 40% on FY2023.

 

Net bank debt on 31 December 2024, following receipt of the proceeds of the disposal of April Six, was £9.4m. As previously outlined, additional receipts of up to a maximum of £4.2m for the earn out payment linked to EBITDA from the April Six transaction are expected.

 

The Value Restoration Plan announced in December 2023 is now complete, as evidenced by the strong margin and profit improvements and significantly reduced bank leverage ratio.

 

The Board was also pleased to publish its updated Capital Allocation Policy on 2 January 2025 with a commitment to return up to £1.5m to shareholders by way of an on-market Share Buyback. The Share Buyback programme has begun and £0.13m has been returned to date. 

 

MISSION will announce its final results on 25 March 2025.

 

Commenting, Mark Lund, Interim Chief Executive Officer of MISSION said:

 

"2024 has seen MISSION not only deliver a resilient trading performance but take great strides to strengthen the business for the future, ensuring we are leaner and less complex with a significantly improved balance sheet.

 

We enter 2025 with momentum and confidence and look forward to capitalising further on this progress as we focus on delivering for our Clients, our people and our shareholders."

 

 

* Footnote

April Six is expected to deliver revenues of £11.8m and a headline operating profit of £1.0m in FY2024 (£0.2m loss in FY2023).

Consensus headline operating profit for 2024 is £9.2m.

 

ENQUIRIES:  

Cat Davis - Group Marketing Director

Via Houston

E: cdavis@themission.co.uk

The MISSION Group PLC

Simon Bridges/Andrew Potts/Harry Rees

020 7523 8000

Canaccord Genuity Limited

(Financial Adviser, Nominated Adviser and Broker)

Peter Tracey

Blackdown Partners Limited

(Financial Adviser)

020 3807 8484

Kate Hoare/Alexander Clelland/India Spencer

0204 529 0549 

E: mission@houston.co.uk

Houston PR

 

 

NOTES TO EDITORS 

The MISSION Group Plc. is The Brand Performance Group.

 

Delivering measurable, results-driven campaigns as the preferred creative partner for real business growth. We offer top-tier agencies, strategic specialisms and global reach delivering outstanding performance for brands. We call it Work That Counts™ www.themission.co.uk 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBRGDBCSDDGUG
Date   Source Headline
24th Sep 20217:30 amRNSHolding(s) in Company
23rd Sep 20216:10 pmRNSDirector/PDMR Shareholding
22nd Sep 20217:00 amRNSInterim Results for six months to 30 June 2021
14th Jul 20217:00 amRNSTRADING UPDATE AND NOTICE OF INTERIM RESULTS
28th Jun 20217:00 amRNSGrowth Share Scheme
25th Jun 20212:17 pmRNSHolding(s) in Company
15th Jun 20217:00 amRNSDirector/PDMR Shareholding
14th Jun 20211:38 pmRNSResult of AGM
14th Jun 20217:00 amRNSTR1: Notification of Major Holdings
11th May 20219:19 amRNSHolding(s) in Company
30th Apr 20217:00 amRNSDirectorate Changes
26th Apr 20215:05 pmRNSCorrection: Director/PDMR Shareholding
26th Apr 202112:15 pmRNSDirector/PDMR Shareholding
19th Apr 20216:04 pmRNSDirector/PDMR Shareholding
14th Apr 20217:01 amRNSFinal Results for the Year Ended 31 December 2020
14th Apr 20217:00 amRNSChanges to the Board
11th Mar 20214:40 pmRNSDirector/PDMR Shareholding
24th Feb 20217:00 amRNSHolding(s) in Company
22nd Feb 20215:37 pmRNSDirector/PDMR Shareholding
9th Feb 20219:24 amRNSDirector/PDMR Shareholding
25th Jan 20214:40 pmRNSSecond Price Monitoring Extn
25th Jan 20214:35 pmRNSPrice Monitoring Extension
20th Jan 20217:00 amRNSTrading Update and Notice of Results
11th Nov 20204:58 pmRNSHolding(s) in Company
23rd Sep 20207:00 amRNSInterim Results
27th Jul 20207:00 amRNSACQUISITION OF INNOVATIONBUBBLE
15th Jul 20207:00 amRNSTrading Statement and Notice of Interim Results
15th Jun 20203:37 pmRNSResult of AGM
21st May 20207:00 amRNSCovid-19 and AGM Update
11th May 20204:58 pmRNSDirector Dealing and Issue of Consideration Shares
17th Apr 20203:36 pmRNSIssue of Equity
7th Apr 20205:00 pmRNSPDMR Shareholding pursuant to Growth Share Scheme
1st Apr 20207:00 amRNSFinal Results for the year ended 31 December 2019
27th Mar 20205:22 pmRNSCOVID-19 UPDATE
25th Mar 202011:05 amRNSSecond Price Monitoring Extn
25th Mar 202011:00 amRNSPrice Monitoring Extension
13th Mar 20202:22 pmRNSHolding(s) in Company
22nd Jan 20207:00 amRNSTrading Update
9th Dec 201911:55 amRNSDirector/PDMR Shareholding
5th Dec 20197:00 amRNSLaunch of Global Competition
25th Sep 20197:00 amRNSChange of Name
25th Sep 20197:00 amRNSHalf-year Report
13th Aug 20197:00 amRNSEBT Share Dealings
7th Aug 20198:15 amRNSEBT Share Dealings
1st Aug 20191:11 pmRNSDirector/PDMR Shareholding - Replacement
1st Aug 20197:00 amRNSDirector/PDMR Shareholding
15th Jul 20197:00 amRNSTrading Update
17th Jun 201912:57 pmRNSResult of AGM
17th Jun 201911:58 amRNSBoard Changes
12th Jun 20195:26 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.